How Assistance Works
Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience
-
1. Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
-
2. Transfer Prescription to AmeriPharma™
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
-
3. Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
-
4. Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma™ Specialty Care has secured $55 million in financial assistance for our patients.
-
5. Nursing Care Coordination
AmeriPharma™ puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
-
6. Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Abraxane?
Abraxane is a chemotherapy medication currently available as a trademarked brand name. It is also available as a generic medication called paclitaxel. It is considered a systemic treatment used to treat metastatic cancer that has spread from one part of the body to another. Being a systemic treatment means that the medication travels through the bloodstream so that it can reach cells in other parts of the body, including cancer cells. Abraxane primarily works by blocking the action of proteins called microtubules, which are proteins that help cells divide. By doing this, it stops cancer cells from dividing and making new cells, and therefore blocks the growth of cancer cells.
Abraxane is available as an injectable solution that is administered intravenously by trained healthcare professionals at the doctor’s office, at clinics, or in hospitals. It is only available with a prescription written by your doctor.
What Is Abraxane Used To Treat?
Abraxane is used to treat a variety of cancers, such as metastatic breast cancer, metastatic pancreatic cancer, and advanced non-small cell lung cancer. More specifically, Abraxane is used for:
- Metastatic breast cancer:
Abraxane is used after there has been failure of combination chemotherapy or relapse within 6 months of adjuvant chemotherapy. Adjuvant therapy is defined as therapy given in addition to the primary or initial therapy to maximize the effectiveness of treatment. The prior therapy that failed should have included an anthracycline unless it was clinically contraindicated. - Metastatic pancreatic cancer:
Abraxane is used as a first-line treatment in combination with another chemotherapy medication called gemcitabine. - Advanced non-small cell lung cancer (NSCLC):
Abraxane is used as a first-line treatment in combination with another chemotherapy medication called carboplatin. For treatment of advanced non-small cell lung cancer with Abraxane, patients cannot be candidates for any type of curative surgery or radiation therapy.
Copay and Financial Assistance
AmeriPharma™ Specialty Care alleviates financial burdens for patients and their families
-
Advanced software locates funding sources to match you with top-dollar foundation programs
-
One of our copay assistance specialists will assist with the application process
-
Automatic updates will be sent to you and your physician on the status of the funding
Directions for Use
Abraxane will be given intravenously (IV) by trained healthcare professionals. Dosage is based on the type of diagnosis. Please see the following:
For metastatic breast cancer:
- The recommended dosage of Abraxane is 260 mg/m2 intravenously over 30 minutes every 3 weeks.
For pancreatic cancer:
- The recommended dosage of Abraxane is 125 mg/m2 intravenously over 30 to 40 minutes on days 1, 8, and 15 out of each 28-day cycle.
- Administer gemcitabine on days 1, 8, and 15 out of each 28-day cycle immediately after Abraxane.
For non-small cell lung cancer:
- The recommended dosage of Abraxane is 100 mg/m2 intravenously over 30 minutes on days 1, 8, and 15 out of each 21-day cycle.
- Administer carboplatin on day 1 out of each 21-day cycle immediately after Abraxane.
A dose may be reduced or discontinued based on severe hematologic, cutaneous, neurologic, or gastrointestinal toxicities.
Abaxane Side Effects
Directions for Use
Abraxane will be given intravenously (IV) by trained healthcare professionals. Dosage is based on the type of diagnosis. Please see the following:
For metastatic breast cancer:
- The recommended dosage of Abraxane is 260 mg/m2 intravenously over 30 minutes every 3 weeks.
For pancreatic cancer:
- The recommended dosage of Abraxane is 125 mg/m2 intravenously over 30 to 40 minutes on days 1, 8, and 15 out of each 28-day cycle.
- Administer gemcitabine on days 1, 8, and 15 out of each 28-day cycle immediately after Abraxane.
For non-small cell lung cancer:
- The recommended dosage of Abraxane is 100 mg/m2 intravenously over 30 minutes on days 1, 8, and 15 out of each 21-day cycle.
- Administer carboplatin on day 1 out of each 21-day cycle immediately after Abraxane.
A dose may be reduced or discontinued based on severe hematologic, cutaneous, neurologic, or gastrointestinal toxicities.
Insurances Accepted
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Get Started in Minutes
Fill out your information and one of our specialists will call you ASAP.
How Much Can You Save?
Speak with a copay assistance specialist
(877) 778-0318
By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices